1.Serum Electrolyte and Acid Base Composition in Patients with Graded Degrees of Chronic Renal Failure.
Ho Yung LEE ; Hyon Young JOO ; Dae Suk HAN
Yonsei Medical Journal 1985;26(1):39-43
One hundred sixty-three patients with graded degrees of uncomplicated stable chronic renal failure were studied to investigate the quantitative relationship between serum acid-base and electrolyte composition and serum creatinine level. Even in patients with a mild degree of renal failure, the serum total carbon dioxide (tCO2) content was reduced significantly. Progressive decrements in tCO2 were noted in the more severe degrees of renal failure with the reciprocal relationship between tCO2 and serum creatinine concentration. Depending upon the degree of chronic renal failure, the type of metabolic acidosis was different. In patients with a moderate degree of renal failure, hyperchloremic acidosis was noted with anion gap remaining normal. As the renal failure progressed to a more severe degree, this pattern of hyperchloremic acidosis changed to anion gap acidosis with a normal serum chloride level. The highest anion gap was 25 mEq/L in the patient with serum creatinine concentration 24.7mg/dL.
Acid-Base Equilibrium*
;
Acidosis/etiology*
;
Adult
;
Carbon Dioxide/blood
;
Chlorides/blood
;
Creatinine/blood
;
Electrolytes/blood*
;
Human
;
Hyperkalemia/etiology
;
Kidney Failure, Chronic/blood*
;
Kidney Failure, Chronic/complications
;
Middle Age
;
Sodium/blood
2.Exploration on the establishment of animal models for gouty nephropathy complicated with chronic renal failure.
Ru-ling XING ; Dong-mei MENG ; Wei REN
Chinese Journal of Integrated Traditional and Western Medicine 2011;31(10):1409-1413
OBJECTIVETo explore the method for establishing animal models of gouty nephropathy complicated with chronic renal failure.
METHODSSix-eight weeks old male Wistar rats were fed with 10% fodder yeast. The adenine at the daily dose of 100, 150, 200, 250, and 300 mg/kg was administrated to them by gastrogavage. The serum levels of blood urea nitrogen (BUN), creatinine (Cr), and uric acid (UA) were dynamically monitored. Meanwhile, the pathological changes of rat kidney were observed.
RESULTSCompared with the normal control group, serum BUN, Cr, and UA obviously increased in rats administered with 100 mg/kg for 7 days (P<0.05). Meanwhile, pathological changes as gouty nephropathy occurred. Along with the prolongation of the modeling time, the aforesaid biochemical indices and pathohistological changes of the kidney were more obvious. The blood Cr level just reached the chronic renal failure level on the 26th day of the administration (about the 4th week), and obviously exceeded the renal failure level on the 41st day (about the 6th week). The blood UA level increased to a higher level on the 7th day of modeling, and maintained at a higher level for a long time. It decreased rapidly from the 41st day to the 48th day. The renal pathological examination showed aggravated infiltration of lymphocytes and stromal fibrous proliferation. On the 48th day of modeling, the proliferation of the fibrous tissue and the interstitial fibrosis were obvious on the bases of the aforesaid changes. The serum BUN, Cr, and blood UA obviously increased in the rats administered with 150, 200, 250, and 300 mg/kg when compared with the normal control group, reaching the level of chronic renal failure (P<0.05). These levels obviously decreased 17 days after restoring to normal fodder feeding, and approached the normal levels till the 35th day.
CONCLUSIONIdeal experimental animal models of gouty nephropathy complicated with chronic renal failure could be established in male Wistar rats by feeding with 10% fodder yeast and 100 mg/kg adenine by gastrogavage for 5 weeks.
Animals ; Disease Models, Animal ; Gout ; complications ; Hyperuricemia ; Kidney Failure, Chronic ; etiology ; Male ; Rats ; Rats, Wistar ; Uric Acid ; blood
3.Severe and persistent hypotension after simultaneous nephrectomy and kidney transplantation in patients with chronic renal failure caused by polycystic kidney disease: Two cases report.
Sang Hyun HONG ; Jae Won HUH ; Jaemin LEE
Anesthesia and Pain Medicine 2015;10(4):301-307
Patients with autosomal dominant polycystic kidney disease have significant morbidity due to large kidney size. Surgical extirpation of polycystic kidneys is frequently necessary to treat the morbidity or to obtain intraabdominal space for a graft kidney. Simultaneous bilateral nephrectomy and kidney transplantation are performed in many transplant centers to avoid the complications associated with anephric states such as anemia requiring blood transfusion, osteodystrophy, fluid overload, hyperkalemia, and congestive heart failure. However, the risk of postoperative complications after combined bilateral nephrectomy with kidney transplantation is relatively high, especially for cases in which the polycystic kidneys are huge. Here, we report two cases of severe and persistent hypotension during and after combined surgery which may have been caused by adrenal insufficiency or by sympathetic denervation and splanchnic vasculature decompression after the removal of huge polycystic kidneys.
Adrenal Insufficiency
;
Anemia
;
Blood Transfusion
;
Decompression
;
Heart Failure
;
Humans
;
Hyperkalemia
;
Hypotension*
;
Kidney Failure, Chronic*
;
Kidney Transplantation*
;
Kidney*
;
Nephrectomy*
;
Polycystic Kidney Diseases*
;
Polycystic Kidney, Autosomal Dominant
;
Postoperative Complications
;
Sympathectomy
;
Transplants
4.Level of asymmetric dimethylarginine and carotid atherosclerosis in patients with chronic kidney disease.
Wei-ru ZHANG ; Fan-fan HOU ; Jian-ping NING ; Xiao-bing YANG ; Qiang WU ; Li-jian TAO ; Ben-mei CHEN ; Hong-yan LI ; Lan CHANG
Journal of Central South University(Medical Sciences) 2006;31(5):621-628
OBJECTIVE:
To determine the association between asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthase, with atherosclerosis in patients with chronic kidney disease (CKD).
METHODS:
One hundred thirty-eight CKD patients were enrolled in this study. Serum levels of L-arginine, ADMA, and SDMA were measured by high-performance liquid chromatography (HPLC). Common carotid arteries intimae-medial thickness (CCA-IMT), cross-sectional calculated intimae-medial thickness (cIM area) and atherosclerotic plaque were detected by noninvasive high-resolution B-mode ultrasonography.
RESULTS:
Serum levels of ADMA and SDMA were significantly increased in CKD patients (n=138) compared with age matched healthy subjects (n=42, P<0.01). ADMA and SDMA levels increased with the progression of renal dysfunction and were negatively related to creatinine clearance (Ccr) in pre-dialysis patients (r=-0.315, P<0.05; r=-0.426, P<0.01). Serum levels of ADMA and SDMA in dialysis patients (n=74) were significantly higher than those in pre-dialysis patients (P<0.05). Patients with carotid artery plaques showed significantly higher levels of ADMA compared with those without plaques. Serum levels of ADMA closely correlated with the mean IMT (r=0.471, P<0.01) and cIM area value (r=0.430, P<0.01). These correlations remained significant even after adjusting GFR, age, gender ,and other risk factors for atherosclerosis in the multiple regression analysis.
CONCLUSION
Serum levels of ADMA increased with the progression of CKD and may play a role in the pathogenesis of accelerated atherosclerosis in CKD patients.
Adult
;
Arginine
;
analogs & derivatives
;
blood
;
Carotid Artery Diseases
;
blood
;
etiology
;
Female
;
Humans
;
Kidney Failure, Chronic
;
blood
;
complications
;
therapy
;
Male
;
Middle Aged
;
Nitric Oxide Synthase
;
antagonists & inhibitors
;
Renal Dialysis
5.The relationship between plasma leptin and nutritional status in chronic hemodialysis patients.
Ja Ryong KOO ; Ky Yong PAK ; Ken Ho KIM ; Rho Won CHUN ; Hyung Jik KIM ; Dong Wan CHAE ; Moon Gi CHOI ; Jung Woo NOH
Journal of Korean Medical Science 1999;14(5):546-551
Leptin serves an important role in suppressing appetite in mice and is known to be elevated in chronic renal failure (CRF) patients. But clinical significance of leptin as an appetite-reducing uremic toxin, remains to be determined. So we studied the relationship between plasma leptin and nutritional status in 46 chronic hemodialysis (HD) patients. Pre HD leptin was measured and divided by body mass index (BMI) to give adjusted leptin levels. KT/Vurea (K, dialyzer urea clearance; T, duration of HD; V, volume of distribution of urea), C-reactive protein (CRP), plasma insulin and nutritional parameters such as serum albumin, normalized protein catabolic rate (nPCR), subjective global assessment (SGA), BMI and mid-arm muscle circumference (MAMC) were also measured. Mean plasma leptin levels were 8.13+/-2.91 ng/mL (male 3.15+/-0.70; female 14.07+/-6.14, p<0.05). Adjusted leptin levels were positively correlated with nPCR (male r=0.47, p<0.05; female r=0.46, p<0.05), SGA (male r=0.43, p<0.05; female r=0.51, p<0.05) and MAMC (male r=0.60, p<0.005; female r=0.61, p<0.05). They did not correlate with KT/Vurea, serum albumin, hematocrit, bicarbonate, insulin and CRP. Presence of DM and erythropoietin therapy had no effect on leptin levels. These results suggest that leptin is a marker of good nutritional status rather than a cause of protein energy malnutrition in chronic HD patients.
Adult
;
Biological Markers/blood
;
Cross-Sectional Studies
;
Female
;
Human
;
Kidney Failure, Chronic/therapy
;
Kidney Failure, Chronic/complications
;
Kidney Failure, Chronic/blood*
;
Leptin/blood*
;
Male
;
Middle Age
;
Nutrition Disorders/etiology
;
Nutrition Disorders/diagnosis
;
Nutritional Status*
;
Obesity/metabolism
;
Obesity/etiology
;
Renal Dialysis*/adverse effects
;
Sex Factors
6.The Effect of Hepatitis C Virus Infection on Insulin Resistance in Chronic Haemodialysis Patients.
Ali OZDEMIR ; Berrin YALINBAS ; Umut SELAMET ; Meltem ERES ; Funda TURKMEN ; Fatma KUMBASAR ; Berna MURAT ; A Tayfun KESKIN ; Yildiz BARUT
Yonsei Medical Journal 2007;48(2):274-280
PURPOSE: To investigate the contribution of HCV infection to insulin resistance in chronic haemodialysis patients. MATERIALS AND METHODS: The study was performed with 55 patients who were on regular haemodialysis therapy three times per week. Of the 55 patients, 34 (20 females and 14 males with an average age of 40.9 years) were anti-HCV (+) and were defined as the HCV (+) group. The remaining 21 patients (8 females and 11 males with an average age of 50 years) were negative for HCV and other viral markers and were defined as the HCV (-) group. BMI of all patients were below 27. Insulin resistance (IR) was calculated according to the HOMA formula and patients were called HOMA-IR (+) if their HOMA scores were higher than 2.5. All of the HOMA-IR (+) patients in both groups were called the HOMA-IR (+) subgroup. None of the patients had a history of drug use or any diseases that were related to insulin resistance except uremia. In both groups and the healthy control group, insulin and glucose levels were studied at three different venous serum samples taken at 5- minute intervals after 12 hours of fasting. Other individual variables were studied at venous serum samples taken after 12 hours of fasting. RESULTS: HOMA scores were (3)2.5 in 22 of 34 HCV (+) patients (64.7%) and 7 of 21HCV (-) patients (33.33%) (p=0.024). Insulin levels of HCV (+) group (13.32 +/- 9.44mIU/mL) were significantly higher than HCV (-) (9.07 +/- 7.39mIU/mL) and the control groups (6.40 +/- 4.94mIU/ mL) (p=0.039 and p=0.021 respectively). HCV (+) patients were younger (40.94 +/- 17.06 and 52.62 +/- 20.64 years, respectively) and had longer dialysis duration (7.18 +/- 3.61 and 2.91 +/- 2.69 years, respectively). Significant positive correlations of HOMA score with insulin (r=0.934, p=0.000) and fasting glucose levels (r=0.379, p=0.043) were found in the HOMA- IR (+) subgroup. Also, a significant positive correlation was found between ALT and insulin levels in the HOMA IR (+) subgroup. C-peptide levels of both HCV (+) and (-) groups were significantly higher than the control group (p < 0.001). There were not any significant correlations between HOMA score and some of the other individual variables including levels of triglyceride, ferritin, ALT, iPTH and Mg in any of the groups. CONCLUSION: In chronic haemodialysis patients; HCV infection is related to a high prevalence of insulin resistance, higher insulin and glucose levels.
*Renal Dialysis
;
Middle Aged
;
Male
;
Kidney Failure, Chronic/*complications
;
*Insulin Resistance
;
Insulin/blood
;
Hyperinsulinism/epidemiology
;
Humans
;
Hepatitis C/*epidemiology
;
Female
;
C-Peptide/blood
;
Adult
7.Association between Vitamin D Deficiency and Anemia in Patients with End-Stage Renal Disease: A Cross-Sectional Study.
Yung Ly KIM ; Hyunwook KIM ; Young Eun KWON ; Dong Ryeol RYU ; Mi Jung LEE ; Kyung Sook PARK ; Han Jak RYU ; Jung Tak PARK ; Hyung Jung OH ; Seung Hyeok HAN ; Tae Hyun YOO ; Shin Wook KANG
Yonsei Medical Journal 2016;57(5):1159-1164
PURPOSE: Despite new treatment strategies, anemia remains the most prevalent complication in patients with end-stage renal disease (ESRD). We investigated whether 25-hydroxyvitamin D [25(OH)D3] deficiency was associated with anemia in ESRD patients. MATERIALS AND METHODS: We reviewed the medical records of 410 ESRD patients who had undergone renal transplantation (RTx) at Yonsei University Health System and who had 25(OH)D3 levels measured at the time of RTx. Patients were divided into two groups based on baseline 25(OH)D3 concentrations: group 1, 25(OH)D3 levels <10 ng/mL; and group 2, 25(OH)D3 levels ≥10 ng/mL. RESULTS: Using multivariate regression models, 25(OH)D3, age, and erythrocyte-stimulating agent (ESA) dose were found to be significantly associated with hemoglobin (Hb) levels [25(OH)D3: β=0.263, p<0.001; age: β=0.122, p=0.010; ESA dose: β=-0.069, p=0.005]. In addition, logistic regression analysis revealed that patients in group 1 had a significantly higher risk for developing anemia (Hb level <10 g/dL) compared to group 2 patients, even after adjusting for potential risk factors for anemia (odds ratio=3.857; confidence interval=1.091-13.632; p=0.036). CONCLUSION: 25(OH)D3 deficiency was significantly associated with anemia in patients with ESRD. Randomized controlled trials are needed to determine whether vitamin D supplementation can improve anemia in these patients.
Adult
;
Aged
;
Anemia/blood/*etiology
;
Calcifediol
;
Cross-Sectional Studies
;
Female
;
Hemoglobin A/analysis
;
Humans
;
Kidney Failure, Chronic/*complications
;
Kidney Transplantation
;
Male
;
Middle Aged
;
Odds Ratio
;
Prevalence
;
Regression Analysis
;
Risk Factors
;
Vitamin D/analogs & derivatives/blood
;
Vitamin D Deficiency/blood/*complications
8.Copeptin in Hemodialysis Patients with Left Ventricular Dysfunction.
Jae Seok KIM ; Jae Won YANG ; Moon Hee CHAI ; Jun Young LEE ; Hyeoncheol PARK ; Youngsub KIM ; Seung Ok CHOI ; Byoung Geun HAN
Yonsei Medical Journal 2015;56(4):976-980
PURPOSE: Copeptin has been considered as a useful marker for diagnosis and prediction of prognosis in heart diseases. However, copeptin has not been investigated sufficiently in hemodialysis patients. This study aimed to investigate the general features of copeptin in hemodialysis and to examine the usefulness of copeptin in hemodialysis patients with left ventricular dysfunction (LV dysfunction). MATERIALS AND METHODS: This study included 41 patients on regular hemodialysis. Routine laboratory data and peptides such as the N-terminal of the prohormone brain natriuretic peptide and copeptin were measured on the day of hemodialysis. Body fluid volume was estimated by bioimpedance spectroscopy, and the E/Ea ratio was estimated by echocardiography. RESULTS: Copeptin increased to 171.4 pg/mL before hemodialysis. The copeptin had a positive correlation with pre-dialysis body fluid volume (r=0.314; p=0.04). The copeptin level decreased along with body fluid volume and plasma osmolality during hemodialysis. The copeptin increased in the patients with LV dysfunction more than in those with normal LV function (218.7 pg/mL vs. 77.6 pg/mL; p=0.01). Receiver operating characteristic curve analysis showed that copeptin had a diagnostic value in the hemodialysis patients with LV dysfunction (area under curve 0.737; p=0.02) and that the cut-off value was 125.48 pg/mL (sensitivity 0.7, specificity 0.8, positive predictive value 0.9, negative predictive value 0.6). CONCLUSION: Copeptin increases in hemodialysis patients and is higher in patients with LV dysfunction. We believe that copeptin can be a useful marker for the diagnosis of LV dysfunction in hemodialysis patients.
Adult
;
Aged
;
Biomarkers/blood
;
Echocardiography
;
Female
;
Glycopeptides/*blood
;
Humans
;
Kidney Failure, Chronic/*blood/complications/therapy
;
Male
;
Middle Aged
;
Natriuretic Peptide, Brain/blood
;
Predictive Value of Tests
;
Prognosis
;
ROC Curve
;
Renal Dialysis/*adverse effects
;
Sensitivity and Specificity
;
Ventricular Dysfunction, Left/*blood/complications/*physiopathology
9.The Mildly Elevated Serum Bilirubin Level is Negatively Associated with the Incidence of End Stage Renal Disease in Patients with IgA Nephropathy.
Ho Jun CHIN ; Hyun Jin CHO ; Tae Woo LEE ; Ki Young NA ; Kook Hwan OH ; Kwon Wook JOO ; Hyung Jin YOON ; Yon Su KIM ; Curie AHN ; Jin Suk HAN ; Suhnggwon KIM ; En Sil JEON ; Dong Chan JIN ; Yong Lim KIM ; Sun Hee PARK ; Chan Duck KIM ; Young Rim SONG ; Seong Gyun KIM ; Yoon Goo KIM ; Jung Eun LEE ; Yoon Kyu OH ; Chun Soo LIM ; Sang Koo LEE ; Dong Wan CHAE ; Won Yong CHO ; Hyoung Kyu KIM ; Sang Kyung JO
Journal of Korean Medical Science 2009;24(Suppl 1):S22-S29
Oxidative stress plays various roles in the development and progression of IgA nephropathy, while bilirubin is known as a potent antioxidant. We therefore hypothesized that serum bilirubin would be associated with renal prognosis in IgA nephropathy. The study subjects comprised 1,458 adult patients with primary IgA nephropathy in Korea. We grouped patients according to the following quartile levels of bilirubin: <0.4 mg/dL (Q1), 0.4-0.5 mg/dL (Q2), 0.6-0.7 mg/dL (Q3), and >0.8 mg/dL (Q4). The outcome data were obtained from the Korean Registry of end-stage renal disease (ESRD). Eighty patients (5.5%) contracted ESRD during a mean follow-up period of 44.9 months. The ESRD incidences were 10.7% in Q1, 8.2% in Q2, 2.8% in Q3, and 2.8% in Q4 (p<0.001). The relative risk of ESRD compared to that in Q1 was 0.307 (95% confidence interval [CI], 0.126-0.751) in Q3 and 0.315 (95% CI, 0.130-0.765) in Q4. The differences of ESRD incidence were greater in subgroups of males and of patients aged 35 yr or more, with serum albumin 4.0 g/dL or more, with normotension, with eGFR 60 mL/min/1.73 m2 or more, and with proteinuria less then 3+ by dipstick test. In conclusion, higher bilirubin level was negatively associated with ESRD incidence in IgA nephropathy.
Adult
;
Bilirubin/*blood
;
Disease Progression
;
Female
;
Glomerular Filtration Rate
;
Glomerulonephritis, IGA/*blood/complications
;
Humans
;
Hypertension/complications
;
Incidence
;
Kidney Failure, Chronic/*blood/complications
;
Male
;
Middle Aged
;
Risk
;
Risk Factors
;
Treatment Outcome
10.A More Appropriate Cardiac Troponin T Level That Can Predict Outcomes in End-Stage Renal Disease Patients with Acute Coronary Syndrome.
Dong Ryeol RYU ; Jung Tak PARK ; Jung Hwa CHUNG ; Eun Mi SONG ; Sun Hee ROH ; Jeong Min LEE ; Hye Rim AN ; Mina YU ; Wook Bum PYUN ; Gil Ja SHIN ; Seung Jung KIM ; Duk Hee KANG ; Kyu Bok CHOI
Yonsei Medical Journal 2011;52(4):595-602
PURPOSE: Cardiac troponin T (cTnT), a useful marker for diagnosing acute myocardial infarction (AMI) in the general population, is significantly higher than the usual cut-off value in many end-stage renal disease (ESRD) patients without clinically apparent evidence of AMI. The aim of this study was to evaluate the clinical usefulness of cTnT in ESRD patients with acute coronary syndrome (ACS). MATERIALS AND METHODS: Two hundred eighty-four ESRD patients with ACS were enrolled between March 2002 and February 2008. These patients were followed until death or June 2009. Medical records were reviewed retrospectively. The cut-off value of cTnT for AMI was evaluated using a receiver operating characteristic (ROC) curve. We calculated Kaplan-Meier survival curves, and potential outcome predictors were determined by Cox proportional hazard analysis. RESULTS: AMIs were diagnosed in 40 patients (14.1%). The area under the curve was 0.98 in the ROC curve (p<0.001; 95% CI, 0.95-1.00). The summation of sensitivity and specificity was highest at the initial cTnT value of 0.35 ng/mL (sensitivity, 0.95; specificity, 0.97). Survival analysis showed a statistically significant difference in all-cause and cardiovascular mortalities for the group with an initial cTnT > or =0.35 ng/mL compared to the other groups. Initial serum cTnT concentration was an independent predictor for mortality. CONCLUSION: Because ESRD patients with an initial cTnT concentration > or =0.35 ng/mL have a poor prognosis, it is suggested that urgent diagnosis and treatment be indicated in dialysis patients with ACS when the initial cTnT levels are > or =0.35 ng/mL.
Acute Coronary Syndrome/blood/complications/*diagnosis/mortality
;
Aged
;
Biological Markers/blood
;
Female
;
Humans
;
Kidney Failure, Chronic/blood/complications/*diagnosis/mortality
;
Male
;
Middle Aged
;
Prognosis
;
Retrospective Studies
;
Sensitivity and Specificity
;
Troponin T/*blood